Who owns Intra Cellular Therapies?

Tip: Access positions for across all investors

Analyze quarterly positions in Intra Cellular Therapies with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Intra Cellular Therapies stock

Who bought or sold Intra Cellular Therapies this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Jpmorgan Chase & Co 143k $9.9M 1600% Mar 2024
 View chart
Simplex Trading 89k $6.2M 297% Mar 2024
 View chart
Jane Street 37k $2.6M 115% Mar 2024
 View chart
Group One Trading 28k $1.9M -21% Mar 2024
 View chart